JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.67% |
| 2 | Technology | 16.04% |
| 3 | Healthcare | 10.96% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Blackstone
BX
$84.7B
| $1.91B | 0.23% |
15,072,997
-632,468
| -4% | -$77.1M |
2013 Q2
35 quarters
|
|
102
Invesco QQQ Trust
QQQ
$507B
| $1.9B | 0.23% |
5,240,784
+304,189
| +6% | +$108M |
2013 Q2
35 quarters
|
|
103
Linde
LIN
$222B
| $1.89B | 0.23% |
5,931,819
+1,148,695
| +24% | +$355M |
2018 Q4
13 quarters
|
|
104
Dover
DOV
$25.5B
| $1.89B | 0.23% |
12,039,850
+731,961
| +6% | +$120M |
2013 Q2
35 quarters
|
|
105
Infosys
INFY
$43.3B
| $1.86B | 0.22% |
74,541,874
+10,570,026
| +17% | +$251M |
2013 Q2
35 quarters
|
|
106
McKesson
MCK
$109B
| $1.83B | 0.22% |
5,965,095
+207,374
| +4% | +$56.4M |
2013 Q2
35 quarters
|
|
107
Oracle
ORCL
$422B
| $1.83B | 0.22% |
22,063,938
+5,237,050
| +31% | +$424M |
2013 Q2
35 quarters
|
|
108
iShares MSCI Japan ETF
EWJ
$23.8B
| $1.82B | 0.22% |
29,565,606
+1,991,149
| +7% | +$126M |
2013 Q2
35 quarters
|
|
109
Freeport-McMoran
FCX
$104B
| $1.77B | 0.21% |
35,678,892
-5,913,557
| -14% | -$262M |
2013 Q2
35 quarters
|
|
110
CME Group
CME
$101B
| $1.77B | 0.21% |
7,451,206
-708,399
| -9% | -$166M |
2013 Q2
35 quarters
|
|
111
O'Reilly Automotive
ORLY
$69.8B
| $1.76B | 0.21% |
38,546,835
-4,245,555
| -10% | -$190M |
2013 Q2
35 quarters
|
|
112
General Dynamics
GD
$88.7B
| $1.74B | 0.21% |
7,203,704
-2,543
| -0% | -$565K |
2013 Q2
35 quarters
|
|
113
Capital One
COF
$122B
| $1.72B | 0.21% |
13,126,745
+586,997
| +5% | +$85.6M |
2013 Q2
35 quarters
|
|
114
Vanguard Information Technology ETF
VGT
$157B
| $1.72B | 0.21% |
33,079,880
+672,368
| +2% | +$34.5M |
2014 Q2
31 quarters
|
|
115
Pfizer
PFE
$159B
| $1.71B | 0.21% |
33,050,325
+2,890,178
| +10% | +$150M |
2013 Q2
35 quarters
|
|
116
Chubb
CB
$133B
| $1.71B | 0.21% |
7,980,897
-1,121,969
| -12% | -$228M |
2013 Q2
35 quarters
|
|
|
PXD
117
DELISTED
Pioneer Natural Resource Co.
PXD
| $1.69B | 0.2% |
6,774,754
+2,082,655
| +44% | +$471M |
2013 Q2
35 quarters
|
|
118
iShares 7-10 Year Treasury Bond ETF
IEF
$41.5B
| $1.63B | 0.2% |
15,206,103
+6,575,655
| +76% | +$730M |
2013 Q2
35 quarters
|
|
119
Walmart Inc
WMT
$883B
| $1.63B | 0.2% |
32,913,654
+1,635,768
| +5% | +$76.8M |
2013 Q2
35 quarters
|
|
120
Zimmer Biomet
ZBH
$17.1B
| $1.63B | 0.2% |
12,772,584
+978,436
| +8% | +$118M |
2013 Q2
35 quarters
|
|
|
121
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$831B
| $1.63B | 0.2% |
3,609,800
-308,700
| -8% | -$137M |
2014 Q3
30 quarters
|
|
122
Abbott
ABT
$171B
| $1.57B | 0.19% |
13,234,893
+3,923,436
| +42% | +$486M |
2013 Q2
35 quarters
|
|
123
Merck
MRK
$352B
| $1.56B | 0.19% |
19,061,623
+881,291
| +5% | +$69.5M |
2013 Q2
35 quarters
|
|
124
JPMorgan BetaBuilders US Mid Cap Equity ETF
BBMC
$2.03B
| $1.55B | 0.19% |
18,147,633
+1,302,672
| +8% | +$110M |
2020 Q3
6 quarters
|
|
125
Synopsys
SNPS
$98B
| $1.55B | 0.19% |
4,655,948
-5,174
| -0.1% | -$1.62M |
2013 Q2
35 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 606 new, 2,655 increased, 2,664 reduced and 677 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 606 new positions and closed 677 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.